Status:
NOT_YET_RECRUITING
First Time Right of Vancomycin
Lead Sponsor:
Erasmus Medical Center
Conditions:
Vancomycin
Pharmacokinetics
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
In 2020, only 16% of the Intensive Care Unit (ICU) patients achieved therapeutic drug concentrations after continuous administration of the first vancomycin dose. Many beneficial population pharmacoki...
Eligibility Criteria
Inclusion
- Adult patients who receive continuous vancomycin treatment at the ICU or orthopaedic department
- Patient or their legal representative is able and willing to sign the Informed Consent Form
Exclusion
- Pregnant woman
- Children
- Patients with a transplantation history
- Patients on continuous renal replacement therapy (CRRT)
- Patients receiving extracorporeal membrane oxygenation (ECMO)
Key Trial Info
Start Date :
October 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2026
Estimated Enrollment :
134 Patients enrolled
Trial Details
Trial ID
NCT05964114
Start Date
October 1 2023
End Date
June 1 2026
Last Update
July 27 2023
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.